OOIR: Observatory of International Research

Papers

(The TQCC of Cancer Radiotherapie is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Stereotactic magnetic resonance imaging-guided radiotherapy for intracardiac metastases: A case report	29
Hypofractionated radiotherapy in the management of rectal tumours	17
Issue Contents	17
Radiotherapy of breast cancer: 2025 update	16
Quality of weight loss during chemoradioherapy in patients with nasopharyngeal cancers	13
Can we predict the cardiac benefit of deep inspiration breath hold for left breast and regional nodal irradiation?	12
Contribution of chemotherapy in immunoradiotherapy combinations	11
Role of radiotherapy in the management of rare solid thoracic tumors of the adults	11
Prognostic factors for 495 nonoperative esophageal squamous cancer patients receiving IMRT plus chemotherapy: A retrospective analysis	11
Neoadjuvant treatment of pancreatic adenocarcinoma: Chemoradiation or stereotactic body radiation therapy?	10
Editorial Board	10
Outcomes of adjuvant lymph node field radiotherapy and immunotherapy for stage III melanoma	10
Extra- and intracranial schwannomas treated with fractionated stereotactic irradiation: Results of a retrospective, multicentric study	9
Nuclear protein in testis (NUT) midline carcinoma of the larynx: A rare case report of a paediatric patient and literature review	9
Role of autophagy in modulating tumor cell radiosensitivity: Exploring pharmacological interventions for glioblastoma multiforme treatment	9
Assurance qualité de la radiothérapie en recherche clinique	8
Effets secondaires endocriniens de la radiothérapie : diagnostic, prévention et traitements	8
Radiation therapy in the thoracic region: Radio-induced cardiovascular disease, cardiac delineation and sparing, cardiac dose constraints, and cardiac implantable electronic devices	8
Études qui changent les pratiques en oncoradiothérapie digestive	8
Surface-guided radiotherapy overview: Technical aspects and clinical applications	8
Issue Contents	8
Use of nanoparticles in radiation oncology	7
Role of radiotherapy in the management of testicular cancer: Recommendations from the French society for radiation oncology	7
Étude de faisabilité : l’utilisation de l’imagerie médicale en éducation thérapeutique en radiothérapie	7
First experiences with an adaptive pelvic radiotherapy system: Analysis of treatment times and learning curve	7

Dosimetric comparison of advanced radiotherapy planning techniques for hippocampal sparing whole brain radiotherapy	7
Stereotactic body radiation therapy for liver metastases in oligometastatic disease	7
Analyse de l’impact des résultats du séquençage de nouvelle génération chez les patients atteints de glioblastome	7
Le rôle de la protonthérapie dans les cancers de l’oesophage	7
Stereotactic body radiation therapy for bone oligometastases	7
La radiothérapie stéréotaxique au Maroc : état des lieux et compatibilité technologique avec les exigences minimales des recommandations internationales de bonne pratique	7
Evolution of radiation oncology training in France: Over 20 years of the role of the Société française des jeunes radiothérapeutes oncologues (SFjRO, the French society of young radiation oncologists)	6
Editorial Board	6
Thoracic reirradiation of recurrent non-small cell lung carcinoma: A comprehensive review	6
Metastasis-directed radiotherapy for non-small cell lung cancer failured under TKI: A case report and literature review	6
Radiotherapy of skin cancers	6
Réirradiation des récidives de carcinomes mammaires	6
Qualitative evaluation of automatic liver segmentation in computed tomography images for clinical use in radiation therapy	6
Role of radiotherapy in the management of brain oligometastases	6
Comprehensive commissioning and quality assurance validation of Ethos™ therapy	6
Quality control of postoperative radiotherapy for non-small cell lung cancer: A study of mediastinal shift	6
Editorial Board	6
Comprehensive analysis of uveal mucosa-associated lymphoid tissue lymphomas: Epidemiological insights and radiotherapy utilization from the Surveillance, Epidemiology and End Results database	6
Application of intraoperative radiotherapy for malignant glioma	5
Fractionated Stereotactic Radiation Therapy for Pituitary Adenomas: An alternative escalating protocol of hypofractionated stereotactic radiotherapy delivering 35 Gy in 5 fractions	5
Combinaison de la radiothérapie interne vectorisée et de la radiothérapie externe	5
Radiotherapy for oral cavity cancers: 2025 update	5
Brachytherapy: An emblematic example of extreme hypofractionated regimen	5
RecoRad™ 4th edition: The Société française de radiothérapie oncologique's “Recommendations” Commission-driven RecoRad™ 2025 updated version	5
Editorial Board	5
Comments on “Ocular proton therapy, pencil beam scanning high energy proton therapy or stereotactic radiotherapy for uveal melanoma; an in silico study”	5
Long-term cardiac mortality in patients treated with radiation for gastric mucosa-associated lymphoid tissue lymphoma	5
Insights on the carbon footprint of radiotherapy in France	5
Dosimetric comparison of different intensity-modulated radiotherapy techniques for whole-breast irradiation of right-breast cancer	5
Tumeurs rares du sein	5
Fibrose pulmonaire radio-induite : nouvelles cibles pour demain	5
Role of stereotactic radiotherapy in the management of small-cell lung cancer	5
Delineation of organs at risk in radiotherapy and perspectives	5
Issue Contents	5
Breast cancer in a transgender man and hypofractionated radiotherapy: A case report and review of literature	5
News in magnetic resonance imaging use for radiation oncology	5
Radiotherapy for nasopharyngeal cancer: 2025 update	5
Hypofractionated radiotherapy for invasive squamous cell carcinoma of the scalp in the elderly: Efficacy and tolerance, preliminary results	5
Spontaneous resolution of intracranial hypertension following radiotherapy for posterior parasagittal meningioma: About two cases and review of the literature	4
Voxel-wise analysis: A powerful tool to predict radio-induced toxicity and potentially perform personalised planning in radiotherapy	4
Radiation therapist, a key player in radiotherapy research	4
Limites de la définition des contraintes de dose pour les organes à risque spécifiques à la radiothérapie stéréotaxique	4
Adaptive radiotherapy	4
Transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma: Long-term results of RTF3 regimen	4
Radiation therapy of the primary tumour and/or metastases of digestive metastatic cancers	4
Patterns of relapse after postoperative radiotherapy in patients with oral cavity cancer and a flap	4
Failure patterns analysis of three-dimensional radiotherapy for stage IV non-small cell lung cancer primary tumours	4
Acute toxicity in patients with high-risk prostate cancer treated with stereotactic body radiation, with irradiation to the prostate and pelvic nodes	4
Hypofractionated radiotherapy in the management of bladder cancer	4
Hypofractionated radiotherapy for pancreatic cancer: What role in 2025?	4

Role of radiotherapy in the management of anal canal cancer: Recommendations of the Société française de radiothérapie oncologique	4
External beam radiotherapy for prostatic cancers: 2025 update	4
Guide for paediatric radiotherapy procedures: 2025 update	4
Breast cancer tumour board: Which patients are eligible for radiotherapy de-escalation or omission?	4
Could conventionally fractionated radiation therapy coupled with stereotactic body radiation therapy improve local control in bone oligometastases?	3
Editorial Board	3
Multicriteria optimization of radiation therapy: Towards empowerment and standardization of reverse planning for head and neck squamous cell carcinoma	3
Dose-escalation in prostate cancer: Results of randomized trials	3
The role of radiation therapy for de novo metastatic bladder and renal cancers	3
Aspects biologiques, précliniques et cliniques de l’association de radiothérapie et d’inhibiteur de CDK 4/6	3
Chemoimmunotherapy for localized non-small cell lung cancer: A new standard for all stage III?	3
Radiotherapy for hypopharynx cancers: 2025 update	3
Hypofractionated postoperative stereotactic radiotherapy for large resected brain metastases	3
Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed radiotherapy	3
Preoperative stereotactic radiotherapy for the management of brain metastases	3
Issue Contents	3
Preoperative ultra-hypofractionation radiotherapy in extremity/trunk wall soft tissue sarcoma — A meta-analysis of prospective studies	3
Radiotherapy needs in French-speaking low- and middle-income countries: Overcoming language barriers for equitable cancer care	3
Permanent alopecia after radiotherapy of primary brain tumours: The most influential factors	3
Radiotherapy and CDK inhibitors: Opportunities and risks	3
Interactions endothélium vasculaire – cellules immunitaires : un point de contrôle clef des lésions digestives radio-induites	3
Issue Contents	3
Contents	3
Place de la radiothérapie stéréotaxique pour les cancers bronchiques non à petites cellules de stade I opérables	3
Health-related quality of life and cognitive failures in patients with lower-grade gliomas treated with radiotherapy	3
Artificial intelligence solution to accelerate the acquisition of MRI images: Impact on the therapeutic care in oncology in radiology and radiotherapy departments	3
Radiotherapy for primary lung cancer: 2025 update	3
Technological innovations in head and neck radiotherapy: What does the future hold?	3
The QuADRANT project: Enhancing quality and safety in radiological procedures through clinical audit	3
Management of cervical lymphadenopathies of unknown primary cancer	3
Is hypofractionated radiotherapy used to treat soft tissue sarcomas? Assessment of practices using the NETSARC network	3
Que faut-il pour faire de la radiothérapie adaptative « online » ?	3
Editorial Board	3
Radiotherapy of bone metastases: 2025 update	3
Orbital follicular lymphoma with large cell component treated with low-dose radiotherapy: A case report and review of literature	3
Practice-changing clinical trials in radiation oncology: A 2024–2025 literature synthesis	3
Evaluating ChatGPT to test its robustness as an interactive information database of radiation oncology and to assess its responses to common queries from radiotherapy patients: A single institution in	3
Impact of radiotherapy schedule on survival of patients treated with immune-checkpoint inhibitors for advanced melanoma and non-small cell lung cancer	3
Pathologie hématologique : le modèle le plus abouti de désescalade en radiothérapie	3
Radiotherapy in the management of synchronous metastatic lung cancer	3
Kinetics of plasma cell-free DNA as a prospective biomarker to predict the prognosis and radiotherapy effect of esophageal cancer	3
Influence de l’immunothérapie sur le choix du traitement des cancers bronchiques non à petites cellules de stade I : point de vue de l’oncologue radiothérapeute	3
Complementary therapies: What are we talking about?	3
Radiotherapy of salivary gland tumours: 2025 update	3
Prognostic significance of different lymph node staging systems in patients with resectable, node-positive, stage III, non-small cell lung cancer: Identifying the optimal classification for enhanced p	3
Cancer de l’endomètre de stade localisé : la perspective d’une désescalade thérapeutique guidée par la classification moléculaire	3
Radiotherapy for rare primary brain tumors	3
Defining the potential for sexual structures-sparing for prostate cancer external beam radiotherapy: A dosimetric study	3
Moderate versus ultra-hypofractionated locoregional breast radiotherapy: Results of a retrospective study during the covid-19 era	3
Radiotherapy and pregnancy: 2025 update	3
Management and work-up procedures of patients with head and neck malignancies treated by radiation: 2025 update	3
What is the future of uterovaginal brachytherapy in private practice in France?	3
Issue Contents	3
Head and neck cancers volume reduction: should we reduce our prophylactic node radiation to spare the antitumor immune response?	3